BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9177373)

  • 1. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood.
    Mullis PE; Yoshimura N; Kuhlmann B; Lippuner K; Jaeger P; Harada H
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1739-45. PubMed ID: 9177373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
    Conte FA; Grumbach MM; Ito Y; Fisher CR; Simpson ER
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene.
    Belgorosky A; Pepe C; Marino R; Guercio G; Saraco N; Vaiani E; Rivarola MA
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5127-31. PubMed ID: 14602738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy.
    Deladoëy J; Flück C; Bex M; Yoshimura N; Harada N; Mullis PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4050-4. PubMed ID: 10566648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.
    Morishima A; Grumbach MM; Simpson ER; Fisher C; Qin K
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3689-98. PubMed ID: 8530621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian and uterine development and hormonal feedback mechanism in a 46 XX patient with CYP19A1 deficiency under low dose estrogen replacement.
    Burckhardt MA; Obmann V; Wolf R; Janner M; Flück CE; Mullis PE
    Gynecol Endocrinol; 2015 May; 31(5):349-54. PubMed ID: 25585547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene.
    Herrmann BL; Saller B; Janssen OE; Gocke P; Bockisch A; Sperling H; Mann K; Broecker M
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5476-84. PubMed ID: 12466340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: lessons from mutations in the genes for aromatase and the estrogen receptor.
    MacGillivray MH; Morishima A; Conte F; Grumbach M; Smith EP
    Horm Res; 1998; 49 Suppl 1():2-8. PubMed ID: 9554463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment.
    Lanfranco F; Zirilli L; Baldi M; Pignatti E; Corneli G; Ghigo E; Aimaretti G; Carani C; Rochira V
    Bone; 2008 Sep; 43(3):628-35. PubMed ID: 18590994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency.
    Verma N; Jain V; Birla S; Jain R; Sharma A
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1185-90. PubMed ID: 23329769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothesis: Persistently elevated hCG causes gestational ovarian overstimulation associated with prolonged postpartum hyperandrogenism in mothers of aromatase-deficient babies.
    Riedl S; Springer A; Häusler G; Price G; Richter-Unruh A; Stener-Victorin E; Wudy SA
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3115-20. PubMed ID: 23824416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of estrogen replacement throughout childhood on growth, pituitary-gonadal axis and bone in a 46,XX patient with CYP19A1 deficiency.
    Janner M; Flück CE; Mullis PE
    Horm Res Paediatr; 2012; 78(4):261-8. PubMed ID: 22964562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome.
    Maffei L; Rochira V; Zirilli L; Antunez P; Aranda C; Fabre B; Simone ML; Pignatti E; Simpson ER; Houssami S; Clyne CD; Carani C
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):218-24. PubMed ID: 17547681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies.
    Bouchoucha N; Samara-Boustani D; Pandey AV; Bony-Trifunovic H; Hofer G; Aigrain Y; Polak M; Flück CE
    Mol Cell Endocrinol; 2014 Jun; 390(1-2):8-17. PubMed ID: 24705274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen: consequences and implications of human mutations in synthesis and action.
    Grumbach MM; Auchus RJ
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4677-94. PubMed ID: 10599737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries.
    Ito Y; Fisher CR; Conte FA; Grumbach MM; Simpson ER
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11673-7. PubMed ID: 8265607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognizing rare disorders: aromatase deficiency.
    Jones ME; Boon WC; McInnes K; Maffei L; Carani C; Simpson ER
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):414-21. PubMed ID: 17452968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters.
    Rochira V; Faustini-Fustini M; Balestrieri A; Carani C
    J Clin Endocrinol Metab; 2000 May; 85(5):1841-5. PubMed ID: 10843162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome.
    Söderlund D; Canto P; Carranza-Lira S; Méndez JP
    Hum Reprod; 2005 Apr; 20(4):965-9. PubMed ID: 15695318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence.
    Belgorosky A; Guercio G; Pepe C; Saraco N; Rivarola MA
    Horm Res; 2009; 72(6):321-30. PubMed ID: 19844120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.